Yasmin Hasan to Polycythemia Vera
This is a "connection" page, showing publications Yasmin Hasan has written about Polycythemia Vera.
Connection Strength
0.141
-
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF). Br J Haematol. 2017 Jan; 176(1):76-85.
Score: 0.141